Literature DB >> 17259344

Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

Angela Sutton1, Veronique Friand, Severine Brulé-Donneger, Thomas Chaigneau, Marianne Ziol, Odile Sainte-Catherine, Aurelie Poiré, Line Saffar, Michel Kraemer, Jany Vassy, Pierre Nahon, Jean-Loup Salzmann, Liliane Gattegno, Nathalie Charnaux.   

Abstract

In addition to their physiologic effects in inflammation and angiogenesis, chemokines are involved in cancer pathology. The aim of this study was to determine whether the chemokine stromal cell-derived factor 1 (SDF-1) induces the growth, migration, and invasion of human hepatoma cells. We show that SDF-1 G protein-coupled receptor, chemokine (C-X-C motif) receptor 4 (CXCR4), and SDF-1 mRNA are expressed in human hepatoma Huh7 cells, which secrete and bind SDF-1. This binding depends on CXCR4 and glycosaminoglycans. SDF-1 associates with CXCR4, and syndecan-4 (SDC-4), a heparan sulfate proteoglycan at the plasma membrane of Huh7 cells, induces the growth of Huh7 cells by promoting their entry into the cell cycle, and inhibits the tumor necrosis factor-alpha-mediated apoptosis of the cells. SDF-1 also reorganizes Huh7 cytoskeleton and induces tyrosine phosphorylation of focal adhesion kinase. Finally, SDF-1 activates matrix metalloproteinase-9, resulting in increased migration and invasion of Huh7 cells. These biological effects of SDF-1 were strongly inhibited by the CXCR4 antagonist AMD3100, by a glycosaminoglycan, heparin, as well as by beta-D-xyloside treatment of the cells, or by c-jun NH(2)-terminal kinase/stress-activated protein kinase inhibitor. Therefore, the CXCR4, glycosaminoglycans, and the mitogen-activated protein kinase signaling pathways are involved in these events. The fact that reducing SDC-4 expression by RNA interference decreased SDF-1-induced Huh7 hepatoma cell migration and invasion strongly indicates that SDC-4 may be an auxiliary receptor for SDF-1. Finally, the fact that CXCR4 is expressed in hepatocellular carcinoma cells from liver biopsies indicates that the in vitro results reported here could be extended to in vivo conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259344     DOI: 10.1158/1541-7786.MCR-06-0103

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  61 in total

Review 1.  Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.

Authors:  Antonio Solinas; Diego F Calvisi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Gene networks in basal cell carcinoma of the eyelid, analyzed using gene expression profiling.

Authors:  Tatsuya Yunoki; Yoshiaki Tabuchi; Tetsushi Hirano; Shigeharu Miwa; Johji Imura; Atsushi Hayashi
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

3.  Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

Authors:  David Zagzag; Mine Esencay; Olga Mendez; Herman Yee; Iva Smirnova; Yuanyuan Huang; Luis Chiriboga; Eugene Lukyanov; Mengling Liu; Elizabeth W Newcomb
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

Review 4.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 5.  Systems Challenges of Hepatic Carcinomas: A Review.

Authors:  Dhatri Madduru; Johny Ijaq; Sujata Dhar; Saumyadip Sarkar; Naresh Poondla; Partha S Das; Silvia Vasquez; Prashanth Suravajhala
Journal:  J Clin Exp Hepatol       Date:  2018-05-17

Review 6.  Syndecans in cartilage breakdown and synovial inflammation.

Authors:  Thomas Pap; Jessica Bertrand
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

7.  Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.

Authors:  Pierre Nahon; Angela Sutton; Pierre Rufat; Chantal Simon; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand; Nathalie Charnaux
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.

Authors:  Wei Zhou; Zheng Jiang; Ningbo Liu; Fenghua Xu; Peie Wen; Yanbing Liu; Weixia Zhong; Xianrang Song; Xiaotian Chang; Xiuli Zhang; Guangsheng Wei; Jinming Yu
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-01       Impact factor: 4.553

9.  Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.

Authors:  Ke Zheng; Hong-Yuan Li; Xin-Liang Su; Xiao-Yi Wang; Tian Tian; Fan Li; Guo-Sheng Ren
Journal:  J Exp Clin Cancer Res       Date:  2010-04-11

10.  Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.

Authors:  Zhen Liu; Da-Xin Sun; Xu-Yong Teng; Wei-Xue Xu; Xiang-Peng Meng; Bao-Sheng Wang
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.